You have no portfolios at this time, click "Manage portfolios" to create your first portfolio.
Data as of Jan 30
Day's Range18.11 - 18.64
52 Wk Range16.153 - 36.86
50 Day Moving Avg.19.813
Drug Manufacturers - Specialty & Generic
What does this company do
Versartis Inc a development stage company was incorporated on December 10, 2008 in the State of Delaware. The Company is a biopharmaceutical company developing therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. The Company is developing novel drug candidates that it has licensed from Amunix Inc. The Company is engaged in developing its novel long-acting recombinant human growth hormone, VRS-317, for growth hormone deficiency, or GHD, and orphan disease. The Company faces competition from pharmaceutical, specialty pharmaceutical and biotechnology companies, generic drug companies, academic institutions and governmental agencies and public and private research institutions.